Home / Compliance actions / 723704

FDA Warning Letter — ProRx LLC

Case 723704 — FEI 3022250654

The FDA took a Warning Letter action against ProRx LLC on Apr 7, 2026 (Exton, PA). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
ProRx LLC
Date
Apr 7, 2026
Fiscal Year
2026
Product Type
Drugs
Center
CDER
Location
Exton, PA (United States)

Facility

Recent inspections

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.